Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kim S J Lao

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
BMC Pulmonary Medicine|July 4, 2024
Prevalence and disease burden of chronic cough in nine cities of China: an observational studyLin Chen, Kim S J Lao, Fang Yi, et al.
CNS Drugs|November 14, 2019
Adverse Events Associated with Melatonin for the Treatment of Primary or Secondary Sleep Disorders: A Systematic ReviewFrank M C Besag, Michael J Vasey, Kim S J Lao, et al.
CNS Drugs|August 24, 2016
Tolerability and Safety Profile of Cariprazine in Treating Psychotic Disorders, Bipolar Disorder and Major Depressive Disorder: A Systematic Review with Meta-Analysis of Randomized Controlled TrialsKim S J Lao, Ying He, Ian C K Wong, et al.
International Journal of Clinical Pharmacy|March 23, 2016
Medication safety research by observational study designKim S J Lao, Celine S L Chui, Kenneth K C Man, et al.
Pharmacoepidemiology and Drug Safety|July 1, 2017
Prescribing trends and indications of antipsychotic medication in Hong Kong from 2004 to 2014: General and vulnerable patient groupsKim S J Lao, Anthony W Y Tam, Ian C K Wong, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|February 13, 2022
Cost-Effectiveness of Midazolam Versus Haloperidol Versus Olanzapine for the Management of Acute Agitation in the Accident and Emergency DepartmentVincent K C Yan, Miriam Haendler, Hayden Lau, et al.
CNS Drugs|October 3, 2020
Antipsychotics and Risk of Neuroleptic Malignant Syndrome: A Population-Based Cohort and Case-Crossover StudyKim S J Lao, Jiaxi Zhao, Joseph Edgar Blais, et al.
CNS Drugs|January 10, 2020
Mortality Risk Associated with Haloperidol Use Compared with Other Antipsychotics: An 11-Year Population-Based Propensity-Score-Matched Cohort StudyKim S J Lao, Angel Y S Wong, Ian C K Wong, et al.
Eclinicalmedicine|March 8, 2021
Intramuscular midazolam, olanzapine, or haloperidol for the management of acute agitation: A multi-centre, double-blind, randomised clinical trialEsther W Chan, Kim S J Lao, Lam Lam, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
BMC Pulmonary Medicine|July 4, 2024
Prevalence and disease burden of chronic cough in nine cities of China: an observational studyLin Chen, Kim S J Lao, Fang Yi, et al.
CNS Drugs|November 14, 2019
Adverse Events Associated with Melatonin for the Treatment of Primary or Secondary Sleep Disorders: A Systematic ReviewFrank M C Besag, Michael J Vasey, Kim S J Lao, et al.
CNS Drugs|August 24, 2016
Tolerability and Safety Profile of Cariprazine in Treating Psychotic Disorders, Bipolar Disorder and Major Depressive Disorder: A Systematic Review with Meta-Analysis of Randomized Controlled TrialsKim S J Lao, Ying He, Ian C K Wong, et al.
International Journal of Clinical Pharmacy|March 23, 2016
Medication safety research by observational study designKim S J Lao, Celine S L Chui, Kenneth K C Man, et al.
Pharmacoepidemiology and Drug Safety|July 1, 2017
Prescribing trends and indications of antipsychotic medication in Hong Kong from 2004 to 2014: General and vulnerable patient groupsKim S J Lao, Anthony W Y Tam, Ian C K Wong, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|February 13, 2022
Cost-Effectiveness of Midazolam Versus Haloperidol Versus Olanzapine for the Management of Acute Agitation in the Accident and Emergency DepartmentVincent K C Yan, Miriam Haendler, Hayden Lau, et al.
CNS Drugs|October 3, 2020
Antipsychotics and Risk of Neuroleptic Malignant Syndrome: A Population-Based Cohort and Case-Crossover StudyKim S J Lao, Jiaxi Zhao, Joseph Edgar Blais, et al.
CNS Drugs|January 10, 2020
Mortality Risk Associated with Haloperidol Use Compared with Other Antipsychotics: An 11-Year Population-Based Propensity-Score-Matched Cohort StudyKim S J Lao, Angel Y S Wong, Ian C K Wong, et al.
Eclinicalmedicine|March 8, 2021
Intramuscular midazolam, olanzapine, or haloperidol for the management of acute agitation: A multi-centre, double-blind, randomised clinical trialEsther W Chan, Kim S J Lao, Lam Lam, et al.
Pageof 1